Abstract Menorrhagia represents a widespread clinical problem, and is the leading cause of elective hysterectomy in women with a normal uterus (D’Esopo 1962; Cole and Berlin 1977; Dyck et al. 1977). Various methods are used to treat this condition, including dilatation and curettage (D&C), hormone therapy, ergot derivatives, anti-fibrinolytic agents, and non-steroidal anti-inflammatory drugs (Nilsson and Rybo 1971). While oral contraceptives appear to be the most effective approach to medical treatment, their usefulness is limited by side-effects and contraindications to therapy. Until recently, women who did not respond to pharmacologic intervention were limited to one of two options: hysterectomy or continued cycles of heavy menstrual bleeding.